Hilary Shmeeda

4.4k citations
42 papers · 3.6k indexed · 1 hit paper · h-index 27
Topics
Nanoparticle-Based Drug Delivery (20 papers)Radiopharmaceutical Chemistry and Applications (10 papers)RNA Interference and Gene Delivery (10 papers)

In The Last Decade

Hilary Shmeeda

41 papers receiving 3.5k citations

Hit Papers

Pharmacokinetics of Pegylated Liposomal Doxorubicin200320262010201820034008001.2k

Peers

Hilary Shmeeda
Comparison fields: 5 of 116
  • Biomaterials 2.0k
  • Molecular Biology 1.7k
  • Biomedical Engineering 1.3k
  • Oncology 669
  • Radiology, Nuclear Medicine and Imaging 379
Replace Tanyel Kiziltepe with:
Tanyel Kiziltepe United States
Natascha Drude Germany
Benjamin A. Teply United States
Wanyi Tai United States
Richard Wooster United States
Olga B. Garbuzenko United States
Rutian Li China
Yuanzeng Min China
Başar Bilgiçer United States
Christopher P. Leamon United States
Hilary Shmeeda relative to Tanyel Kiziltepe United States Tanyel Kiziltepe's profile →
Citations per field
00.5×1.7×
Tanyel Kiziltepe · 1×
Citations per year

Countries citing papers authored by Hilary Shmeeda

Since Specialization
Citations

This map shows the geographic impact of Hilary Shmeeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary Shmeeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary Shmeeda more than expected).

Fields of papers citing papers by Hilary Shmeeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilary Shmeeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary Shmeeda. The network helps show where Hilary Shmeeda may publish in the future.

Co-authorship network of co-authors of Hilary Shmeeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hilary Shmeeda. A scholar is included among the top collaborators of Hilary Shmeeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilary Shmeeda. Hilary Shmeeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 18
4 35
5 15
6 35
7 86
8 57
9 62
10 2
11 67
12 64
13 97
14 77
15 99
16
Intracellular delivery of liposome-encapsulated zoledronic acid via folate receptor results in significant inhibition of tumor cell growth
1
17 105
18
Pharmacokinetics of Pegylated Liposomal Doxorubicinbreakdown →
1317
19 41
20 149

About Hilary Shmeeda

Hilary Shmeeda is a scholar working on Biomaterials, Toxicology and Oncology, having authored 42 papers that have together received 3.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Biomaterials (2.0k citations), Pharmaceutical Science (234 citations) and Biomedical Engineering (1.3k citations). Hilary Shmeeda has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Alberto Gabizón, Yechezkel Barenholz, Samuel Zalipsky, Dina Tzemach, Yasmine Amitay, Lidia Mak, Aviva T. Horowitz, Jenny Gorin, Patricia Ohana and Dorit Goren. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026